We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Ash Board PhD

Ash Board PhD

Editorial Director

Contact Us

Ash started with Technology Networks as an editor in 2010 having previously worked in marketing communications roles within the scientific industry. He holds a PhD in Chemistry from the University of Nottingham where he researched the active site of enzymes. Ash oversees the editorial, social media and custom content teams, helping set the direction of the publication.


Latest Content
Genomic Testing Service To Drive Personalized Medicine for Cancer Patients
Industry Insight

Genomic Testing Service To Drive Personalized Medicine for Cancer Patients

The service will enable oncologists, hematologists and other healthcare professionals to undertake rapid and extensive genomic analysis of cancer samples on an unprecedented scale in the UK.
Improved Characterization of Antibody-Drug Conjugates
Article

Improved Characterization of Antibody-Drug Conjugates

In a new research study published in Analytical Chemistry, scientists showcase a novel mass spectrometry-based method that enables high-throughput characterization of ADCs. Technology Networks spoke to Eli J. Larson, lead author of the paper, to learn more about the method and some of the benefits it offers over existing analytical techniques.
Addressing the Challenges of Small Molecule Analysis
Industry Insight

Addressing the Challenges of Small Molecule Analysis

Despite small molecule research spanning many fields, the characterization and identification protocols are often not as good as they should be. We spoke to Andreas Huhmer from Thermo Fisher Scientific to learn how the company's latest mass spectrometer helps address these issues.
Opinionated Science Episode 17: I Got COVID-19: Here's What Happened
Podcast

Opinionated Science Episode 17: I Got COVID-19: Here's What Happened

This episode is a COVID-19 podcast with a first-hand focus. Podcast host Ruairi Mackenzie discusses his experience with symptomatic COVID-19. And we also look at the data around COVID-19 risk and age and discuss the emerging problems posed by long COVID.
Opinionated Science Episode 16: The Metabolome: The Way to Personalized Healthcare?
Podcast

Opinionated Science Episode 16: The Metabolome: The Way to Personalized Healthcare?

In this episode, the team discuss the metabolome; the billions of tiny molecules that our cells produce every second. Scientific understanding of the metabolome has leapt forward, opening the door to a better understanding of how to treat disease, how to live a healthier lifestyle and even how trauma can be passed down via our metabolites.

Opinionated Science Episode 13: Connecting the Brain: “Thought Tetris”, Brain Privacy and Neuralink
Podcast

Opinionated Science Episode 13: Connecting the Brain: “Thought Tetris”, Brain Privacy and Neuralink

In this episode, the team discuss efforts to let your brain communicate beyond the limits of your head. Whilst much of this research is still in early stages, scientists have shown how individuals can share thoughts through brain wave-based games of Tetris, and tech entrepreneurs have looked to a future where brains can be directly joined with computers. We look into these technologies’ potential to help paralysis patients and the ethical implications of a network of interconnected brains.
Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing
News

Wuhan COVID-19 Vaccine Trials Show Early Positive Results, Moving Forward to Phase 3 Testing

The adenovirus type-5-vectored COVID-19 vaccine was shown to be safe and induced significant immune responses in the majority of recipients after a single immunization.
Opinionated Science Episode 7: The Vagus Nerve: A Target to Treat Brain and Body?
Podcast

Opinionated Science Episode 7: The Vagus Nerve: A Target to Treat Brain and Body?

In this episode, we review the evidence surrounding vagus nerve stimulation (VNS), a therapy approved for epilepsy and depression that backers now want to use to treat a host of other conditions, include autoimmune disease and heart failure. How can scientists fill in the gaps in the VNS knowledge base?
First-of-its-Kind Cyclic IMS Promises Unlimited Experimental Opportunities
Industry Insight

First-of-its-Kind Cyclic IMS Promises Unlimited Experimental Opportunities

Ion mobility spectrometry (IMS) coupled to mass spectrometry (MS) has witnessed significant growth over the last two decades. To better understand IMS, the benefits this technology provides, and exactly what Waters' new SELECT SERIES CyclicTM IMS offers, we spoke to Emma Marsden-Edwards.
Waters’ Highly Flexible SYNAPT XS Offers Freedom of Analytical Choice
Industry Insight

Waters’ Highly Flexible SYNAPT XS Offers Freedom of Analytical Choice

A highly flexible and high-resolution mass spectrometer, the SYNAPT™ XS technology from Waters has been developed with the analytical needs of R&D labs in mind. Joanne Ballantyne tells us more about the development of SYNAPT™ XS and the features to which it lends its versatility.
Advertisement